Journal of Microencapsulation

Papers
(The H4-Index of Journal of Microencapsulation is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Development, systematic optimisation and biofilm disruption activity of eugenol-based nanosized emulsions stabilised with Tween 8044
β-Cyclodextrin-functionalized nanocarriers for bromocriptine: development, evaluation and histopathological studies37
Advancements in microneedle technology: current status and next-generation innovations31
Applications of propolis encapsulation in food products26
Synergistic effect of DR5-targeted capsules loaded with doxorubicin in drug-resistant 3D tumour spheroids17
Her-2 nanobody modified cisplatin nanoparticles for precise chemotherapy of colon cancer17
Hyaluronic acid–functionalised solid lipid nanoparticles for enhanced oral uptake and therapeutic efficacy in rheumatoid arthritis16
Impregnation of polyethylene terephthalate (PET) grafts with BMP-2 loaded functional nanoparticles for reconstruction of anterior cruciate ligament16
The pH-controlled release properties of chitosan–gold nanoparticles encapsulated nobiletin to induce apoptosis through PI3K/AKT/mTOR signalling pathway on gastric cancer cell lines16
Recent developments in sustained-release and targeted drug delivery applications of solid lipid nanoparticles14
Poly(lactic acid)/β-cyclodextrin based nanoparticles bearing ruthenium(II)-arene naproxen complex: preparation and characterisation. Analytical validation for metal determination by microwave-induced 14
Chitooligosaccharide-catechin conjugate loaded liposome using different stabilising agents: characteristics, stability, and bioactivities13
L-Ascorbic acid and phosphatidylcholine complex vesicles: formation and elucidation of their biological activities, and their molecular interactions13
Intra-articular treatment of osteoarthritis using novel biocompatible etoricoxib chitosan-hyaluronate hybrid microparticles13
Cellulose-based hydrogels enhanced with bioactive molecules for optimal chronic diabetic wound management13
0.052789211273193